BioSpace News Archive

Nu Skin Enterprises, Inc. (NYSE: NUS) today announced its board of directors has declared a quarterly cash dividend of $0.365 per share which will be paid on Sep. 12, 2018, to stockholders of record on Aug. 31, 2018.

Quarterly revenue of $558 million, up 14% over prior year; GAAP EPS of $0.73 and adjusted EPS of $0.83

Collaboration with Preeminent Rho Kinase (ROCK) Inhibitor R&D Organization to Explore Novel Compounds for Glaukos’ iDoseTM Drug Delivery System

REPORTS EPS OF $0.52 AND ADJUSTED EPS OF $0.53 ON REVENUES OF $152 MILLION

Aug. 2, 2018 20:30 UTC Navitor Pharmaceuticals Appoints Thomas E. Hughes, Ph.D. as Chief Executive Officer Former CEO and President of Zafgen brings pharmaceutical development and public biotechnology company leadership experience as Navitor builds product pipeline George P. Vlasuk, Ph.D. to remain as President and appointed Chief Scientific Officer CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Navito

Cellectis announced the appointment of Dr. Stefan Scherer, M.D., Ph.D., to the role of Senior Vice President Clinical Development and Deputy Chief Medical Officer.

Select Medical Holdings Corporation announced results for its second quarter ended June 30, 2018.

Health Canada testing of “Jian Pai Natural Skin Care Cream,” also called ''Yikangshuang,” found that it contains two antifungal drugs (fluconazole and miconazole) that are not listed on the product label, and may pose serious health risks.

Hologic, Inc. announced that the Company will present at the Canaccord Genuity 38th Annual Growth Conference in New York, NY on Wednesday, August 8 at 1:30 p.m. Eastern Time.

Eli Lilly and Company announced that its subsidiary, Elanco Animal Health, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO) of common stock.